Detalles de la búsqueda
1.
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
N Engl J Med
; 388(7): 595-608, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791160
2.
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Clin Infect Dis
; 78(1): 202-209, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698366
3.
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Clin Infect Dis
; 78(6): 1732-1744, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253338
4.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904987
5.
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Clin Infect Dis
; 70(10): 2073-2081, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31340042
6.
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
J Infect Dis
; 217(10): 1616-1625, 2018 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29401325
7.
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
J Infect Dis
; 215(1): 24-33, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694633
8.
Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.
Clin Immunol
; 169: 16-27, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27236001
9.
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Hum Vaccin Immunother
; 16(6): 1327-1337, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31951765
10.
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
Vaccine
; 37(14): 2004-2015, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30850240
11.
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.
J Gerontol A Biol Sci Med Sci
; 74(8): 1217-1224, 2019 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30256905
12.
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.
Front Immunol
; 8: 943, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28855902
13.
Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.
Clin Vaccine Immunol
; 21(3): 302-11, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24391139
14.
Persistence clinical studies: can you believe what you see?
Hum Vaccin Immunother
; 9(6): 1351-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857273
15.
Immunogenicity and safety of a booster dose of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine coadministered with the tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers: a randomized trial.
Pediatr Infect Dis J
; 32(1): 62-71, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23076383
Resultados
1 -
15
de 15
1
Próxima >
>>